Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Environmental Topics
Laws & Regulations
About EPA
Menu
Environmental Topics
Laws & Regulations
About EPA
Related Topics:
EPA National Library Network
Contact Us
Search Results for the EPA National Library Catalog
Items Found: 690
Showing: Items 201 - 250
Your Search: (SUBJECT=Drug)
Sort Results:
Publication dates (newest-oldest)
Publication dates (oldest-newest)
Title
Choose a Library:
(CTRL-CLICK for multiple libraries)
Search all libraries
Capital Group(All DC-area libraries)
AWBERC Library/Cincinnati,OH
CCTE/GLTED Library/Duluth,MN
CEMM/ACESD Library/Narragansett,RI
CEMM/EPD Library/Athens,GA
CEMM/GEMMD Library/Gulf Breeze,FL
CPHEA/PESD Library/Corvallis,OR
Env Science Center Library/Ft Meade,MD
Headquarters Library/Washington,DC
Law Library/Washington,DC
NRMRL/GWERD Library/Ada,OK
NVFEL Library/Ann Arbor, MI
OCSPP Chemical Library/Washington,DC
Region 1 Library/Boston,MA
Region 2 Library/New York,NY
Region 3 Library/Philadelphia, PA
Region 4 Library/Atlanta,GA
Region 5 Library/Chicago,IL
Region 6 Library/Dallas,TX
Region 8 Technical Library/Denver,CO
Region 9 Library/San Francisco,CA
Region 10 Library/Seattle,WA
Research Triangle Park Library/RTP, NC
Choose a Collection:
(CTRL-CLICK for multiple collections)
Search all collections
books
documents
journals
reference
audiovisual
ebooks
PREV
1
2
3
4
5
6
7
8
9
10
11
12
...
14
NEXT
Select Item
Title
Year Published
201
Economic Impact of Implementing Volatile Organic Compound Group II Regulations in Ohio
1981
202
Economic impact of implementing volatile organic compound group II regulations in Ohio /
1981
203
Effect of Aggregation on 'Vibrio cholerae' Inactivation.
1994
204
Effect of Ampicillin-Induced Alterations in Murine Intestinal Microbiota on the Survival and Competition of Environmentally Released Pseudomonads.
1989
205
Effect of Phenobarbital and 3-Methylcholanthrene on Aldehyde Dehydrogenase Activity in Cultures of HepG2 Cells and Normal Human Hepatocytes. (Revised).
1987
206
Effect of Wastewater Disinfectants on Survival of R-Factor Coliform Bacteria.
1987
207
Effects of convulsant agents on learning and memory in squirrel monkeys /
1993
208
Effects of foods and drugs on the development and function of the nervous system : methods for predicting toxicity : proceedings of the Fifth FDA Science Symposium, held at the Hospitality House, Arlington, Virginia, October 10-12, 1979 /
1980
209
Effects of formaldehyde on xenotransplanted human respiratory epithelium /
1992
210
Effects of hormones, drugs and chemicals on testicular function /
1980
211
Effects of ozone and nitrogen dioxide on lung function in healthy and asthmatic adolescents
1987
212
Effects of perchloroethylene/drug interaction on behavior and neurological function /
1977
213
Effects of pesticides on the immune response /
1979
214
Effects of Selected Anti-Tumor-Promoting Chemicals on Metabolic Cooperation between Chinese Hamster V79 Cells.
1994
215
Effects on human health of subtherapeutic use of antimicrobials in animal feeds
1980
216
Efficient Multiple-Exposure Analysis of the Toxicity of Crisnatol: A DNA Intercalator in Phase 2 Clinical Trials.
1992
217
Elimination of Urinary Cotinine in Children Exposed to Known Levels of Side-Stream Cigarette Smoke.
1987
218
Encyclopedic reference of immunotoxicology
2005
219
Endocrine disrupters : environmental health and policies /
2001
220
Endocrine toxicology /
1985
221
Endocrine toxicology.
2010
222
Enforceability Aspects for RACT (Reasonably Available Control Technology) for the Chemical Synthesis Pharmaceutical Industry.
1981
223
Environmental Assessment and Overview of Biotechnology Process Applications.
1984
224
Environmental assessment of the proposed effluent guidelines for the pharmaceutical manufacturing industry.
1995
225
Environmental chemical exposures and immune system integrity : proceedings of the Workshop on the Relationship between Environmental Chemical Exposures and the Integrity of the Immune System, September 16, 1986 /
1987
226
Environmental endocrine disrupters : an evolutionary perspective /
2000
227
Environmental endocrine-disrupting chemicals : neural, endocrine, and behavioral effects /
1998
228
Environmental hormones : the scientific basis of endocrine disruption /
2001
229
Environmental neurotoxicology
1992
230
Environmental toxicology and pharmacology of human development
1997
231
Enzymatic basis of detoxication
1980
232
Enzyme systems that metabolise drugs and other xenobiotics /
2002
233
EPA Office of Compliance Sector Notebook Project. Profile of the pharmaceutical manufacturing industry.
1997
234
Epidemiology of Poisoning.
1968
235
Estimation of the dose-response curve for human developmental toxicants : final report for Task 2-31 /
1987
236
Evaluation of Behavioral Teratogenic Effects.
1987
237
Evaluation of biological treatment of pharmaceutical wastewater with PAC addition /
1988
238
Evaluation of biological treatment of pharmaceutical wastewater with PAC addition {microform}, volume 2. Appendices /
1988
239
Evaluation of certain veterinary drug residues in food : forty-third report of the Joint FAO/WHO Expert Committee on Food Additives.
1995
240
Evaluation of certain veterinary drug residues in food : sixtieth report of the Joint FAO/WHO Expert Committee on Food Additives.
2003
241
Evaluation of certain veterinary drug residues in food : sixty-second report of the Joint FAO/WHO Expert Committee on Food Additives.
2004
242
Evaluation of certain veterinary drug residues in food : thirty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives.
1990
243
Event-Related Brain Potentials: An Alternative Methodology for Neurotoxicological Research.
1983
244
Evidence for Chromosomal Replicons as Units of Sister Chromatid Exchanges.
1989
245
Evidence for Monoaminergic Involvement in Triadimefon-Induced Hyperactivity.
1989
246
Evidence That Drug-Resistant Alloreactive T Cells May Contribute to Human Graft Rejection.
1990
247
Examining the public health risks of carcinogens in consumer products : hearing before the Subcommittee on Economic and Consumer Policy of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 12, 2019.
2019
248
Experimental and clinical neurotoxicology /
2000
249
Extrapolation of dosimetric relationships for inhaled particles and gases
1989
250
FDA premarket approval process of approving Ansaid as a drug : report to Congressional requesters /
1992
PREV
1
2
3
4
5
6
7
8
9
10
11
12
...
14
NEXT
Save, Print or Email Selected Records
Select Records
Selected (this page only)
Selected (across pages)
All (this page only)
All (all pages - 500 item maximum)
Select Format
Text (Brief Information)
Text (Full Information)
Endnote (Endnote Import)
ASCII delimited for EXCEL
Email Address:
(if applicable)